Augmented antitumor activity by olaparib plus AZD1775 in gastric cancer through disrupting DNA damage repair pathways and DNA damage checkpoint

BACKGROUND: Targeting poly ADP-ribose polymerase (PARP) has been recently identified as a promising option against gastric cancer (GC). However, PARP inhibitors alone achieve limited efficacy. Combination strategies, especially with homologous recombination (HR) impairment, are of great hope to opti...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Xiaoting, Chen, Dongshao, Zhang, Cheng, Zhang, Xiaotian, Li, Zhongwu, Dong, Bin, Gao, Jing, Shen, Lin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6027790/
https://www.ncbi.nlm.nih.gov/pubmed/29954437
http://dx.doi.org/10.1186/s13046-018-0790-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6027790/
https://www.ncbi.nlm.nih.gov/pubmed/29954437
http://dx.doi.org/10.1186/s13046-018-0790-7

Ejemplares similares